Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 12:58 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 169–192 of 4,175 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control comparison Clear all

Conditions: Depression
Interventions: Supportive Therapy SSI, Behavioral Activation SSI, Growth Mindset SSI; Behavioral
Lead sponsor: Stony Brook University; Other
Eligibility: 13 Years to 16 Years
Enrollment: 2,452 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Urge Urinary Incontinence, Urinary Frequency
Interventions: Oxybutynin, Placebo; Drug
Lead sponsor: Antares Pharma Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 626 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 55
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Laguna Hills, California + 50 more

Conditions: Urinary Urge Incontinence
Interventions: Revi System Treatment, Revi System - Delayed Activation; Device
Lead sponsor: BlueWind Medical; Industry
Eligibility: 18 Years and older
Enrollment: 117 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 19
States / cities: Tucson, Arizona • Pasadena, California • Riverside, California + 16 more

Conditions: HIV-1-Infection
Interventions: ISL/LEN, Antiretroviral Combinations; Drug
Lead sponsor: Gilead Sciences; Industry
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 49
States / cities: Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 41 more

Conditions: Pain, Postoperative, Amputation
Interventions: Liposomal bupivacaine, Bupivacaine Hydrochloride 0.5 % Injectable Solution; Drug
Lead sponsor: Aurora Quaye; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Portland, Maine

Conditions: Healthy
Interventions: Not listed
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 159 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Headache
Interventions: Prochlorperazine, Ketamine, Diphenhydramine, Ondansetron, Normal Saline; Drug
Lead sponsor: University Medical Center of Southern Nevada; Other
Eligibility: 18 Years to 65 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Cataract, Multifocal Intraocular Lens
Interventions: Clareon PanOptix Pro and Clareon Vivity Intraocular Lens, Clareon PanOptix Pro Intraocular Lenses; Device
Lead sponsor: Brian Shafer; Other
Eligibility: 18 Years and older
Enrollment: 346 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 5
States / cities: Baltimore, Maryland • Alexandria, Minnesota • Bozeman, Montana + 2 more

Conditions: Pediatric Heart Failure
Interventions: LCZ696, Enalapril, Placebo of LCZ696, Placebo of Enalapril; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 1 Month to 17 Years
Enrollment: 393 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 25
States / cities: Loma Linda, California • Los Angeles, California • Palo Alto, California + 20 more

Conditions: Alcohol Drinking, Alcohol Use Disorder
Interventions: Video; Behavioral
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: San Diego, California

Conditions: Rheumatoid Arthritis
Interventions: AD 452; Drug
Lead sponsor: Sosei; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 232 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2005
U.S. locations: 10
States / cities: Clearwater, Florida • Fort Lauderdale, Florida • Ocala, Florida + 7 more

Conditions: Hearing Loss, Hearing Loss, Sensorineural, Cochlear Hearing Loss
Interventions: Diagnostic tests of cochlear implant or acoustic hearing function, Targeted aural rehabilitation of the poorer performing ear; Diagnostic Test · Behavioral
Lead sponsor: University of Maryland, College Park; Other
Eligibility: 18 Years to 85 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 2
States / cities: Bethesda, Maryland • College Park, Maryland

Conditions: Healthy
Interventions: 0.5mg AZ-010; placebo, 1mg AZ-010, 3mg AZ-010, AZ-010 1mg, IV Granisetron 1mg, Placebo; Combination Product · Drug · Other
Lead sponsor: Nova Pneuma Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Tempe, Arizona

Conditions: Type 2 Diabetes, Obesity, Pediatric Obesity
Interventions: Lifestyle Intervention; Behavioral
Lead sponsor: Arizona State University; Other
Eligibility: 10 Years to 99 Years
Enrollment: 132 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: HIV Prevention, HIV Infections
Interventions: Tenofovir, HEC Placebo, Open label tenofovir tablet; Drug
Lead sponsor: CONRAD; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 2
States / cities: Los Angeles, California • Pittsburgh, Pennsylvania

Conditions: Uncontrolled Hypertension
Interventions: Baxdrostat, Placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 130 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 10
States / cities: Phoenix, Arizona • Tempe, Arizona • Montclair, California + 6 more

Conditions: Fentanyl, Platelet Reactivity
Interventions: Morphine, Fentanyl; Drug
Lead sponsor: Corewell Health South; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Saint Joseph, Michigan

Conditions: Cancer, Other Than Non-melanoma Skin Cancer
Interventions: Mobile Mindfulness Meditation, Mindfulness Coach; Behavioral
Lead sponsor: University of Hawaii; Other
Eligibility: 21 Years and older
Enrollment: 302 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 2
States / cities: Palo Alto, California • Honolulu, Hawaii

Conditions: Port Wine Stains
Interventions: Rapamycin cream, Pulsed dyed laser; Drug · Procedure
Lead sponsor: AFT Pharmaceuticals, Ltd.; Industry
Eligibility: Up to 10 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Corpus Christi, Texas

Conditions: Dental Caries
Interventions: UDMA-K18 smooth surface sealant; Device
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 12 Years to 89 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Surgical Incisions
Interventions: adhesive to suture; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 21 Years and older · Female only
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Huntington Disease
Interventions: SAGE-718, Placebo; Drug
Lead sponsor: Supernus Pharmaceuticals, Inc.; Industry
Eligibility: 25 Years to 65 Years
Enrollment: 69 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 13
States / cities: Birmingham, Alabama • Los Alamitos, California • Englewood, Colorado + 10 more

Conditions: Anaemia
Interventions: Daprodustat, Darbepoetin alfa, Placebo, Iron Therapy; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 3,872 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 161
States / cities: Andalusia, Alabama • Birmingham, Alabama • Huntsville, Alabama + 128 more

Conditions: Myelodysplastic Syndrome
Interventions: Maitake; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Testing Scalable, Single-Session Interventions for Adolescent Depression in the Context of COVID-19

Study of Topically Administered Oxybutynin Gel in Patients With Urge Incontinence

RESTORE: An RCT to Evaluate the Efficacy of the Revi System

Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1

Liposomal Bupivacaine vs Continuous Nerve Catheters for Below the Knee Amputations

Comparison Study of a New Fiberoptic Intubation Device to Standard Intubation Techniques

The CHECK Trial: A Comparison of Headache Treatment in the ED: Compazine Versus Ketamine

Visual Outcomes in Patients Contralaterally Implanted With PanOptix Pro and Clareon Vivity Compared to Bilateral Implantation of PanOptix Pro

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week, Double-blind Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Failure

Alcohol Misuse Intervention in Active Duty US Navy Personnel

A Multicentre Trial to Determine the Efficacy of AD 452 in RA Subjects.

Optimizing Bilateral and Single-sided-deafness Cochlear Implants for Functioning in Complex Auditory Environments

Staccato® Granisetron Single Dose PK

Preventing Diabetes in Latino Families

Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet

A Study to Evaluate Cortisol Reserve in Response to Adrenocorticotropic Hormone (ACTH) Stimulation Test Following Baxdrostat Treatment Compared to Placebo in Participants With Uncontrolled Hypertension

Platelet Reactivity With Fentanyl, Morphine, or no Narcotic

Mobile Mindfulness Meditation Intervention to Improve the Well-Being of Cancer Survivors

Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains

Prevention of Enamel Demineralization by Use of K18-smooth Surface Sealant

HISTOACRYL: A Study of Its Efficacy in Final Scar Formation

28-Day Study of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)

Does Maitake Mushroom Extract Enhance Hematopoiesis in Myelodysplastic Patients?